on 08 Dec 2020
Last Applicant/ Owned by
Minato-ku Tokyo 108-0071
JP
Serial Number
79279654 filed on 09th Jul 2019
Registration Number
6213624 registered on 08th Dec 2020
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Reagents for medical purposes or medical reagents for diagnostic purposes; chemical preparations for pharmaceutical or medical purposes, namely, for treating vision failure, hearing failure, bone growth failure, lung failure, heart failure, articular failure, mental disorders, central nervous system disorder, blood disorders, skin disorders, pain, inflammation, kidney failure, liver failure, fibro Read More
Chemicals for use in stabilization of RNA before purification and after purification under laboratory experiment and medical examination; chemical reagents for separating, detecting, measuring and analyzing proteins; ribonucleic acid (RNA) for laboratory use; nuclease for scientific or laboratory purposes; unsticking and separating preparations for scientific or laboratory purposes; chemicals for use in industry and science; artificial sweeteners; reagents for medical research
Reagents for medical purposes or medical reagents for diagnostic purposes; chemical preparations for pharmaceutical or medical purposes, namely, for treating vision failure, hearing failure, bone growth failure, lung failure, heart failure, articular failure, mental disorders, central nervous system disorder, blood disorders, skin disorders, pain, inflammation, kidney failure, liver failure, fibrosis, metabolic disorders, endocrine diseases, gynecological diseases, respiratory diseases, cardiovascular diseases, tissue regeneration and cancer; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for preventing and treating infectious diseases; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; reagent paper for medical purposes; gauze for dressings; capsules sold empty for pharmaceuticals; adhesive plasters for medical purposes; dental materials, namely, implants comprising living tissues; dietary supplements for humans
Testing, inspecting, analyzing, surveying, and research and development relating to pharmaceuticals; testing, inspecting or researching of medical technologies, and providing information and consultancy services relating thereto; research and development of pharmaceuticals and medical supplies; providing information relating to research of pharmaceuticals and medical supplies; testing, inspecting or researching of chemicals for medical use; quality evaluation and analysis of functions of chemical compositions available for medical purposes; providing information on medical researches; DNA analysis services for scientific research purposes; cytogenetic testing for scientific research purposes; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing temporary use of on-line non-downloadable computer programs for drug candidate discovery tools on data networks; designing of machines, apparatus, instruments including their parts or systems composed of such machines, apparatus and instruments; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research in the field of machines, apparatuses and instruments in the field of detection of trace components, hazardous substances and microorganisms
No 79279654
No Service Mark
No 610.094-319
No
No
No
No
No
No
No
No
26.11.21 -
Rectangles that are completely or partially shaded
26.11.25 -
Rectangles with one or more curved sides
Status Date | Action Taken |
---|---|
04th Apr 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
11th Mar 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
11th Mar 2021 | FINAL DISPOSITION PROCESSED |
08th Mar 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
08th Dec 2020 | REGISTERED-PRINCIPAL REGISTER |
22nd Sep 2020 | PUBLISHED FOR OPPOSITION |
22nd Sep 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
18th Sep 2020 | REFUSAL PROCESSED BY IB |
02th Sep 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
20th Aug 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |